Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine

British Journal of Pharmacology

Volumn 126, Issue 1, 1999, Pages 317-325

  Barker, Diana M ^a   Corder, Roger ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adenylate cyclase; Corticotrophin releasing factor; CRF receptor; Endothelium; Guanylate cyclase; K+ channels; Nitric oxide; Sauvagine; Vasodilatation

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ARGININE METHYL ESTER; CORTICOTROPIN RELEASING FACTOR; DEOXYCHOLIC ACID; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL; POTASSIUM ION; SAUVAGINE;

ANIMAL TISSUE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; DRUG POTENCY; ISOLATED ARTERY; MALE; NITRIC OXIDE RELEASE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; SUPERIOR MESENTERIC ARTERY; THORACIC AORTA;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; CORTICOTROPIN-RELEASING HORMONE; DEOXYCHOLIC ACID; DETERGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM; ENZYME INHIBITORS; GLYBURIDE; HYPOGLYCEMIC AGENTS; MALE; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; PEPTIDES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; TETRAETHYLAMMONIUM; THIOUREA; VASODILATION; VASODILATOR AGENTS;

EID: 0032952774     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702261     Document Type: Article

References (45)

1. BARKER, D.M. & CORDER, R. (1995). The long-lasting vasodilator action of corticotrophin releasing hormone is endotheliumdependent in the rat perfused mesentery. Br. J. Pharmacol., 115.42P.
2. BOLOTINA, V.M., NAJIBI, S., PALACINO, J.J., PAGANO, P.J. & COHEN, R.A. (1994). Nitric oxide directly activates the calciumdependent potassium channels in vascular smooth muscle. Nature, 368, 850-851.
3. BROWN, M.R., FISHER, L.A., SPIESS, J., RIVIER, J., RIVIER, C. & VALE, W. (1982a). Comparison of the biologic actions of corticotrophin releasing factor and sauvagine. Regul. Pept., 4, 107-114.
4. BROWN, M.R., FISHER, L.A., SPIESS, J., RIVIER, C., RIVIER, J. & VALE, W. (1982b). Corticotrophin releasing factor: Actions on the sympathetic nervous system and metabolism. Endocrinology, 111,928-931.
5. CHANG, C.P., PEARSE II, R.V., O1 CONNELL, S. & ROSENFELD, M.G. (1993). Identification of a seven transmembrane helix receptor for corticotrophin releasing factor and sauvagine in mammalian brain. Neuron. 11, 1187-1195.
6. CORDER, R., TURNILL, D., LING, N. & GAILLARD, R.C. (1992). Attenuation of corticotrophin releasing factor-induced hypertension in anesthetised rats with the CRF antagonist, a-helical CRF9_4i; comparison with effect on ACTH release. Pcpliilcs, 13, 1-6.
7. DASHWOOD, M.R., ANDREWS, H.E. & WEI, E.T. (1987). Binding of [125I]Tyr-corticotrophin releasing factor to rabbit aorta is reduced by removal of the endothelium. Enr. J. Pharmacol., 135,111-112.
8. EDWARDS, G. & WESTON, A.H. (1993). The pharmacology of ATPsensitive potassium channels. Ann. Rev. Pharmacol. Toxicol., 33, 597-637.
9. FRANCOS, J.A., HUANG, T.Y. & CLARK, C.B. (1996). Steady shear and step changes in shear stimulate endothelium via independent mechanisms - superposition of transient and sustained nitric oxide production. Biochem. Biophys. Res. Commun., 224, 660665.
10. GARCIA-CARDENA, G., FAN, R., SHAH, V., SORRENTINO, R., CIRINO, G., PAPAPETROPOULOS, A. & SESSA, W.C. (1998). Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature, 392, 821 -824.
11. GARDINER, S.M., COMPTON, A.M. & BENNETT, T. (1988). Regional haemodynamic effects of depressor neuropeptides in conscious unrestrained Long Evans and Brattleboro rats. Br. J. Pharmacol., 95, 197-208.
12. GARLAND, C.J. & McPHERSON, G.A. (1992). Evidence that nitric oxide does not mediate the hyperpolarisation and relaxation to acetylcholine in the rat small mesentery. Br. J. Pharmacol., 105, 429-435.
13. GERRITSEN, M.E. & LEDERIS, K. (1979). Urotensin I effects on intracellular content of cyclic AMP in the rat tail artery. Eur. J. Pharmacol., 60, 211-220.
14. GRAVES, J. & POSTON, L. (1993). /J-adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. Br. J. Pharmacol., 108, 631-637.
15. GRUNT, M., GLASER, J., SCHMIDHUBER, H., PAUSCHINGER, P. & BORN, J. (1993). Effects of corticotrophin releasing factor on isolated heart activity. Am. J. Physiol., 264, Hl 124-H1129.
16. GRYGLEWSKI, R.J., MONCADA, S. & PALMER, R.M.J. (1986). Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br. J. Pharmac., 87,685-694.
17. HUTCHESON, I.R. & GRIFFITH, T.M. (1994). Heterogenous populations of K+ channels mediate EDRF release to flow but not agonists in rabbit aorta. Am. J. Physiol., 266, H590-H596.
18. JAIN, V., VENDERNIKOV, Y.P., SAADE, G.R., CHWALISZ, K. & GARFIELD, R.E. (1997). The relaxation responses to corticotropin-releasing factor in rat aorta are endothelium dependent and gestationally regulated. Am. J. Obstet. Gynecol.. 176, 234240.
19. KANNAN, M.S. & JOHNSON, D.E. (1995). Modulation of nitric oxidedependent relaxation of pig trachéal smooth muscle by inhibitors of guanylyl cyclase and calcium activated potassium channels. Life Sei., 56, 2229-2238.
20. KISHIMOTO, T., PEARSE II, R.V., LIN, C.R. & ROSENFELD, M.G. (1995). A sauvagine/corticotrophin releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sei. USA. 92, 1108-1112.
21. KONTOS, H.A. & WEI, E.P. (1993). Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by méthylène blue and by LY83583. Stroke, 24, 427-434.
22. LANGTON, P.D., NELSON, M.T., HUANG, Y. & STANDEN, N.B. (1991). Block of calcium-activated potassium channels in arterial myocytes by tetraethylammonium ions. Am. J. Physiol., 260, H927-H934.
23. LEDERIS, K., LETTER, A., McMASTER, D., MOORE, G. & SCHLESINGER, D. (1982). Complete amino acid sequence of urotensin I, a hypotensive and corticotrophin releasing neuropeptide from Catastomus. Science, 218, 162-164.
24. LEDERIS, K. & MEDAKOVIC, M. (1974). Pharmacological observations on the hypotensive actions of extracts of teleost fish urophyses (urotensin I) in the rat. Br. J. Pharmocol., 51, 315324.
25. LEI, S., RICHTER, R., BIENERT, M. & MULVANY, M.J. (1993). Relaxing actions of corticotrophin releasing factor on rat resistance arteries. Br. J. Pharmacol., 108, 941 -947.
26. LENZ, H.J., FISHER, L.A., VALE, W. & BROWN, M.R. (1985). Corticotrophin releasing factor, sauvagine and urotensin I: Effects on blood flow. Am. J. Physiol.. 249, R85-R90.
27. LIAW, C.W., GRIGORIADIS, D.E., LORANG, M.T., DE SOUZA, E.B. & MAKI, R.A. (1997). Localization of agonist- and antagonistbinding domains of human corticotrophin-releasing factor receptors. Mol. Emlocrinol., 11, 2048-2053.
28. LOVENBERG, T.W., CHALMERS, D.T., LIU, C. & DE SOUZA, E.B. (1995). CRF2a and CRF2/J receptor mRNAs are differently distributed between the rat central nervous system and peripheral tissues. Endocrinology, 136,4139-4142.
29. LUO, D., DAS, S. & VINCENT, S.R. (1995). Effects of méthylène blue and LY83583 on neuronal nitric oxide synthase and NADPHdiaphorase. Eur. J. Pharmacol., 290, 247-51.
30. MACCANNELL, K.L., LEDERIS, K., HAMILTON, P. & RIVIER, J. (1982). Amunine (ovine CRF), urotensin I and sauvagine, three structurally related peptides, produce selective dilation of the mesenteric circulation. Pharmacology, 25, 116-120.
31. MCPHERSON, G.A. & ANGUS, J.A. (1991). Evidence that acetylcholine-mediated hyperpolarisation of the rat small mesenteric artery does not involve the K+ channel opened by cromakalim. Br. J. Pharmacol., 103, 1184-1190.
32. MONTECUCCHI, P.C., ANASTASI, A., DE CASTIGLIONE, R. & ERSPAMER, V. (1980). Isolation and amino acid composition of Sauvagine. Int. J. Peptide and Protein Res., 16, 191 -199.
33. MORLEY, S.D., SCHÖNROCK, C., RICHTER, D., OKAWARA, Y. & LEDERIS, K. (1991). Corticotrophin (CRF) gene family in the brain of the teleost fish Catostonms commersoni (white sucker): molecular analysis predicts distinct precursors for two CRFs and one urotensin I peptide. Mol. Marine Biol. and Biolech., 1, 4857.
34. MORO, M.A., RUSSELL, R.J., CELLEK, S., LIZASOAIN, L, SU, Y., DARLEY-USMAR, V.M., RADOMSKI, M.W. & MONCADA, S. (1996). cGMP mediates the vascular and platelet actions of nitric oxide: conformation using an inhibitor of the soluble guanylyl cyclase. Proc. Nail. Acad. Sei. U.S.A., 93, 1480-1485.
35. PARSONS, S.J.W., HILL, A., WALDRON, G.J., PLANE, F. & GARLAND, C.J. (1994). The relative importance of nitric oxide and nitric oxide-independent mechanisms in acetylcholine-evoked dilatation of the rat mesenteric bed. Br. J. Pharmacol., 113, 1275-1280.
36. RAPACON, M., MIEYAL, P., McGIFF, J.C., FULTON, D. & QUILLEY, J. (1996). Contribution of calcium-activated potassium channels to the vasodilator effect of bradykinin in the isolated, perfused kidney of the rat. Br. J. Pharmacol., 118, 1504-1508.
37. ROHDE, E., FURKERT, J., FECHNER, K., BEYERMANN, M., MULVANY, M.J., RICHTER, R.M., DENEF, C., BIENERT, M. & BERGER, H. (1996). Corticotrophin-releasing hormone (CRH) receptors in the mesenteric small arteries of rats resemble the (2)subtype. Biochcm. Pharmacol., 52, 829-833.
38. SCHÜRMEYER, T.H., GOLD, P.W., GALLUCI, W.T., TOMAI, T.P., CUTTLER, G.B. JR., LORIAUX, D.L. & CHROUSOS, G.P. (1985). Effects and pharmokinetic properties of the rat/human corticotrophin releasing factor in rhesus monkeys. Endocrinology, 117, 300-306.
39. SHELDON, R.J., JIANG, Q., PORRECA, F. & FISHER, L.A. (1990). Gastrointestinal motor effects of corticotrophin releasing factor in mice. Regul. Pepl., 28, 137-151.
40. SOUTHAN, G.J., SZABo, C. & THIEMERMANN, C. (1995). Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br. J. Pharmacol., 114, 510-516.
41. STENZEL-POORE, M.P., HELDWEIN, K.A., STENZEL, P., LEE, S. & VALE, W. (1992). Characterisation of the genomic corticotrophin releasing factor (CRF) gene from Xenopus laevis: Two members of the CRF family exist in amphibians. Mol. Endocrin., 6, 17161724.
42. UDELSMAN, R., GALLUCCI, W.T., BACHER, J., LORIAUX, D.L. & CHROUSOS, G.P. (1986). Haemodynamic effects of corticotrophin releasing factor in the anaesthetised cynomolus monkey. Peptides,7,465-41.
43. VALE,W.,SPIESS,J., RIVIER,C.& RIVIER, J. (1981). Characterisation of a 41 residue ovine hypothalamic peptide that stimulates secretion of corticotrophin and /5-endorphin. Science. 213, 13941397.
44. VAUGHAN, J., DONALDSON, C, BITTENCOURT, J., PERRIN, M.H., LEWIS, K., SUTTON, S., CHAN, R., TURNBULL, A.V., LOVEJOY, D., RIVIER, C, RIVIER, J., SAWCHENKO, P.E. & VALE, W. (1995). Urocortin, a mammalian neuropeptide related to fish urotensin I and corticotrophin releasing factor. Nature, 378, 287-292.
45. WILLIAMS, C.L., PETERSON, J.M., VILLAR, R.G. & BURKS, T.F. (1987). Corticotrophin releasing factor directly mediates colonie responses to stress. Am. J. Physiol., 253, G582-G586.